Active, Not Recruiting
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
NCT04496960
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States